| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.4M | +881.4% |
| Cost of Revenue | $15.0M | +41.8% |
| Gross Profit | -$11.6M | -13.5% |
| R&D Expense | $6.6M | -20.5% |
| SG&A Expense | $12.2M | -17.8% |
| Operating Income | -$52.7M | -26.2% |
| Net Income | -$51.0M | -28.9% |
| EPS (Basic) | -$0.02 | — |
| EPS (Diluted) | -$0.02 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $15.9M | -42.4% |
| Accounts Receivable | $92K | +253.8% |
| Inventory | $24.3M | +29.8% |
| Current Assets | $47.0M | -28.4% |
| Total Assets | $72.7M | -32.4% |
| Current Liabilities | $12.4M | -14.3% |
| Total Liabilities | $19.6M | -22.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.4M | -0.3% |
| Capital Expenditures | $1.2M | -90.0% |
| Investing Cash Flow | $11.2M | -69.0% |
| Financing Cash Flow | $14.5M | -6.4% |
| Free Cash Flow | -$39.6M | +21.7% |
| Stockholders' Equity |
| $53.1M |
| -35.5% |